Replication and hematological characterization of human platelet reactivity genetic associations in men from the Caerphilly Prospective Study (CaPS)

Journal of Thrombosis and Thrombolysis

Volumn 41, Issue 2, 2016, Pages 343-350

  Eicher, John D ^a,b   Xue, Luting ^a,c   Ben Shlomo, Yoav ^d   Beswick, Andrew D ^d   Johnson, Andrew D ^a,b  

^a FRAMINGHAM HEART STUDY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c BOSTON UNIVERSITY   (United States)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Blood platelets; Platelet aggregation; Platelet count; SNPs; Thrombin

Indexed keywords

ADENOSINE DIPHOSPHATE; D DIMER; HEMOGLOBIN; THROMBIN; CELL SURFACE RECEPTOR; EPINEPHRINE; HISTONE DEMETHYLASE; JMJD1C PROTEIN, HUMAN; MEMBRANE PROTEIN; MRVI1 PROTEIN, HUMAN; N DEMETHYLASE; PEAR1 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PHOSPHOPROTEIN; PIK3CG PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE COUNT; GENE; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEMATOCRIT; HUMAN; HUMAN CELL; JMJD1C GENE; MALE; MIDDLE AGED; MRVI1 GENE; PEAR1 GENE; PIK3CG GENE; PLATELET REACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RGS18 GENE; SHH GENE; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; CLINICAL TRIAL; DRUG EFFECTS; GENETICS; METABOLISM; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL;

ADENOSINE DIPHOSPHATE; CLASS IB PHOSPHATIDYLINOSITOL 3-KINASE; EPINEPHRINE; HUMANS; JUMONJI DOMAIN-CONTAINING HISTONE DEMETHYLASES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; OXIDOREDUCTASES, N-DEMETHYLATING; PHOSPHOPROTEINS; PLATELET AGGREGATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CELL SURFACE;

EID: 84956932581     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-015-1290-7     Document Type: Article

References (36)

1. Hennekens CH, Dyken ML, Fuster V (1997) Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 96:2751–2753
2. Johnson AD (2011) The genetics of common variation affecting platelet development, function and pharmaceutical targeting. J Thromb Haemost 9(Suppl 1):246–257
3. Johnson AD, Yanek LR, Chen MH, Faraday N, Larson MG, Tofler G, Lin SJ, Kraja AT, Province MA, Yang Q, Becker DM, O’Donnell CJ, Becker LC (2010) Genome-wide meta-analyses identifies seven loci associated with platelet aggregation in response to agonists. Nat Genet 42:608–613
4. Kauskot A, Vandenbriele C, Louwette S, Gijsbers R, Tousseyn T, Freson K, Verhamme P, Hoylaerts MF (2013) PEAR1 attenuates megakaryopoiesis via control of the PI3K/PTEN pathway. Blood 121:5208–5217
5. Kauskot A, Di MM, Loyen S, Freson K, Verhamme P, Hoylaerts MF (2012) A novel mechanism of sustained platelet alphaIIbbeta3 activation via PEAR1. Blood 119:4056–4065
6. Edelstein LC, Luna EJ, Gibson IB, Bray M, Jin Y, Kondkar A, Nagalla S, Hadjout-Rabi N, Smith TC, Covarrubias D, Jones SN, Ahmad F, Stolla M, Kong X, Fang Z, Bergmeier W, Shaw C, Leal SM, Bray PF (2012) Human genome-wide association and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stress. Circulation 125:2762–2771
7. The Caerphilly and Speedwell Collaborative Group (1984) Caerphilly and Speedwell collaborative heart disease studies. The Caerphilly and Speedwell Collaborative Group. J Epidemiol Community Health 38:259–262
8. Elwood PC, Renaud S, Sharp DS, Beswick AD, O’Brien JR, Yarnell JW (1991) Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. Circulation 83:38–44
9. Renaud S, Godsey F, Dumont E, Thevenon C, Ortchanian E, Martin JL (1986) Influence of long-term diet modification on platelet function and composition in Moselle farmers. Am J Clin Nutr 43:136–150
10. Sharp DS, Ben-Shlomo Y, Beswick AD, Andrew ME, Elwood PC (2005) Platelet aggregation in whole blood is a paradoxical predictor of ischaemic stroke: Caerphilly Prospective Study revisited. Platelets 16:320–328
11. Elwood PC, Beswick AD, Sharp DS, Yarnell JW, Rogers S, Renaud S (1990) Whole blood impedance platelet aggregometry and ischemic heart disease. The Caerphilly Collaborative Heart Disease Study. Arteriosclerosis 10:1032–1036
12. Beswick AD, O’Brien JR, Limb ES, Yarnell JW, Elwood PC (1994) Shear-induced filter blockage. A population based appraisal of a method for the assessment of platelet, white cell and von Willebrand factor interactions. Platelets 5:186–192
13. Sweetnam PM, Yarnell JW, Lowe GD, Baker IA, O’Brien JR, Rumley A, Etherington MD, Whitehead PJ, Elwood PC (1998) The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studies. Br J Haematol 100:582–588
14. Rumley A, Lowe GD, Sweetnam PM, Yarnell JW, Ford RP (1999) Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study. Br J Haematol 105:110–116
15. Lowe GD, Yarnell JW, Sweetnam PM, Rumley A, Thomas HF, Elwood PC (1998) Fibrin D-dimer, tissue plasminogen activator, plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study. Thromb Haemost 79:129–133
16. Lowe GD, Rumley A, Sweetnam PM, Yarnell JW, Rumley J (2001) Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study. Thromb Haemost 86:822–827
17. Gieger C, Radhakrishnan A, Cvejic A, Tang W, Porcu E, Pistis G, Serbanovic-Canic J, Elling U, Goodall AH, Labrune Y, Lopez LM, Magi R, Meacham S, Okada Y, Pirastu N, Sorice R, Teumer A, Voss K, Zhang W, Ramirez-Solis R, Bis JC, Ellinghaus D, Gogele M, Hottenga JJ, Langenberg C, Kovacs P, O’Reilly PF, Shin SY, Esko T, Hartiala J, Kanoni S, Murgia F, Parsa A, Stephens J, van der Harst P, Ellen van der Schoot C, Allayee H, Attwood A, Balkau B, Bastardot F, Basu S, Baumeister SE, Biino G, Bomba L, Bonnefond A, Cambien F, Chambers JC, Cucca F, D’Adamo P, Davies G, de Boer RA, de Geus EJ, Doring A, Elliott P, Erdmann J, Evans DM, Falchi M, Feng W, Folsom AR, Frazer IH, Gibson QD, Glazer NL, Hammond C, Hartikainen AL, Heckbert SR, Hengstenberg C, Hersch M, Illig T, Loos RJ, Jolley J, Khaw KT, Kuhnel B, Kyrtsonis MC, Lagou V, Lloyd-Jones H, Lumley T, Mangino M, Maschio A, Mateo Leach I, McKnight B, Memari Y, Mitchell BD, Montgomery GW, Nakamura Y, Nauck M, Navis G, Nothlings U, Nolte IM, Porteous DJ, Pouta A, Pramstaller PP, Pullat J, Ring SM, Rotter JI, Ruggiero D, Ruokonen A, Sala C, Samani NJ, Sambrook J, Schlessinger D, Schreiber S, Schunkert H, Scott J, Smith NL, Snieder H, Starr JM, Stumvoll M, Takahashi A, Tang WH, Taylor K, Tenesa A, Lay TS, Tonjes A, Uda M, Ulivi S, van Veldhuisen DJ, Visscher PM, Volker U, Wichmann HE, Wiggins KL, Willemsen G, Yang TP, Hua ZJ, Zitting P, Bradley JR, Dedoussis GV, Gasparini P, Hazen SL, Metspalu A, Pirastu M, Shuldiner AR, van Joost PL, Zwaginga JJ, Boomsma DI, Deary IJ, Franke A, Froguel P, Ganesh SK, Jarvelin MR, Martin NG, Meisinger C, Psaty BM, Spector TD, Wareham NJ, Akkerman JW, Ciullo M, Deloukas P, Greinacher A, Jupe S, Kamatani N, Khadake J, Kooner JS, Penninger J, Prokopenko I, Stemple D, Toniolo D, Wernisch L, Sanna S, Hicks AA, Rendon A, Ferreira MA, Ouwehand WH, Soranzo N (2011) New gene functions in megakaryopoiesis and platelet formation. Nature 480:201–208
18. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575
19. Qayyum R, Becker LC, Becker DM, Faraday N, Yanek LR, Leal SM, Shaw C, Mathias R, Suktitipat B, Bray PF (2015) Genome-wide association study of platelet aggregation in African Americans. BMC Genet 16:58
20. Jones CI, Bray S, Garner SF, Stephens J, de Bono B, Angenent WG, Bentley D, Burns P, Coffey A, Deloukas P, Earthrowl M, Farndale RW, Hoylaerts MF, Koch K, Rankin A, Rice CM, Rogers J, Samani NJ, Steward M, Walker A, Watkins NA, Akkerman JW, Dudbridge F, Goodall AH, Ouwehand WH (2009) A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways. Blood 114:1405–1416
21. Kim Y, Suktitipat B, Yanek LR, Faraday N, Wilson AF, Becker DM, Becker LC, Mathias RA (2013) Targeted deep resequencing identifies coding variants in the PEAR1 gene that play a role in platelet aggregation. PLoS One 8:e64179
22. Lewis JP, Ryan K, O’Connell JR, Horenstein RB, Damcott CM, Gibson Q, Pollin TI, Mitchell BD, Beitelshees AL, Pakzy R, Tanner K, Parsa A, Tantry US, Bliden KP, Post WS, Faraday N, Herzog W, Gong Y, Pepine CJ, Johnson JA, Gurbel PA, Shuldiner AR (2013) Genetic variation in PEAR1 is associated with platelet aggregation and cardiovascular outcomes. Circ Cardiovasc Genet 6:184–192
23. Faraday N, Yanek LR, Yang XP, Mathias R, Herrera-Galeano JE, Suktitipat B, Qayyum R, Johnson AD, Chen MH, Tofler GH, Ruczinski I, Friedman AD, Gylfason A, Thorsteinsdottir U, Bray PF, O’Donnell CJ, Becker DM, Becker LC (2011) Identification of a specific intronic PEAR1 gene variant associated with greater platelet aggregability and protein expression. Blood 118:3367–3375
24. Wurtz M, Nissen PH, Grove EL, Kristensen SD, Hvas AM (2014) Genetic determinants of on-aspirin platelet reactivity: focus on the influence of PEAR1. PLoS One 9:e111816
25. Xiang Q, Cui Y, Zhao X, Zhao N (2013) Identification of PEAR1 SNPs and their influences on the variation in prasugrel pharmacodynamics. Pharmacogenomics 14:1179–1189
26. Sokol J, Biringer K, Skerenova M, Stasko J, Kubisz P, Danko J (2015) Different models of inheritance in selected genes in patients with sticky platelet syndrome and fetal loss. Semin Thromb Hemost 41:330–335
27. Qayyum R, Snively BM, Ziv E, Nalls MA, Liu Y, Tang W, Yanek LR, Lange L, Evans MK, Ganesh S, Austin MA, Lettre G, Becker DM, Zonderman AB, Singleton AB, Harris TB, Mohler ER, Logsdon BA, Kooperberg C, Folsom AR, Wilson JG, Becker LC, Reiner AP (2012) A meta-analysis and genome-wide association study of platelet count and mean platelet volume in African Americans. PLoS Genet 8:e1002491
28. Soranzo N, Spector TD, Mangino M, Kuhnel B, Rendon A, Teumer A, Willenborg C, Wright B, Chen L, Li M, Salo P, Voight BF, Burns P, Laskowski RA, Xue Y, Menzel S, Altshuler D, Bradley JR, Bumpstead S, Burnett MS, Devaney J, Doring A, Elosua R, Epstein SE, Erber W, Falchi M, Garner SF, Ghori MJ, Goodall AH, Gwilliam R, Hakonarson HH, Hall AS, Hammond N, Hengstenberg C, Illig T, Konig IR, Knouff CW, McPherson R, Melander O, Mooser V, Nauck M, Nieminen MS, O’Donnell CJ, Peltonen L, Potter SC, Prokisch H, Rader DJ, Rice CM, Roberts R, Salomaa V, Sambrook J, Schreiber S, Schunkert H, Schwartz SM, Serbanovic-Canic J, Sinisalo J, Siscovick DS, Stark K, Surakka I, Stephens J, Thompson JR, Volker U, Volzke H, Watkins NA, Wells GA, Wichmann HE, Van Heel DA, Tyler-Smith C, Thein SL, Kathiresan S, Perola M, Reilly MP, Stewart AF, Erdmann J, Samani NJ, Meisinger C, Greinacher A, Deloukas P, Ouwehand WH, Gieger C (2009) A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet 41:1182–1190
29. Katoh M, Katoh M (2007) Comparative integromics on JMJD1C gene encoding histone demethylase: conserved POU5F1 binding site elucidating mechanism of JMJD1C expression in undifferentiated ES cells and diffuse-type gastric cancer. Int J Oncol 31:219–223
30. Sroczynska P, Cruickshank VA, Bukowski JP, Miyagi S, Bagger FO, Walfridsson J, Schuster MB, Porse B, Helin K (2014) shRNA screening identifies JMJD1C as being required for leukemia maintenance. Blood 123:1870–1882
31. Shakya A, Callister C, Goren A, Yosef N, Garg N, Khoddami V, Nix D, Regev A, Tantin D (2015) Pluripotency transcription factor Oct4 mediates stepwise nucleosome demethylation and depletion. Mol Cell Biol 35:1014–1025
32. Wolf SS, Patchev VK, Obendorf M (2007) A novel variant of the putative demethylase gene, s-JMJD1C, is a coactivator of the AR. Arch Biochem Biophys 460:56–66
33. Hirsch E, Bosco O, Tropel P, Laffargue M, Calvez R, Altruda F, Wymann M, Montrucchio G (2001) Resistance to thromboembolism in PI3Kgamma-deficient mice. FASEB J 15:2019–2021
34. Hirsch E, Lembo G, Montrucchio G, Rommel C, Costa C, Barberis L (2006) Signaling through PI3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing. Thromb Haemost 95:29–35
35. Lian L, Wang Y, Draznin J, Eslin D, Bennett JS, Poncz M, Wu D, Abrams CS (2005) The relative role of PLCbeta and PI3Kgamma in platelet activation. Blood 106:110–117
36. Satyanarayana A, Gudmundsson KO, Chen X, Coppola V, Tessarollo L, Keller JR, Hou SX (2010) RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis. Blood 116:2921–2931